
Sign up to save your podcasts
Or


Episode 2 goes from the negotiation room into the text of the treaty – to unpick what access and benefit sharing of Marine Genetic Resources really means. We explore what the treaty means in practice for scientists and commercial end users, what the provisions hold for Indigenous Peoples and local communities, and the relevance for future generations.
Guests
Co-Producers
Editing
Communications
Further readingHumphries, F. (ed.) (2025). Decoding Marine Genetic Resource Governance under the BBNJ Agreement (Springer) Chapter 5 (BBNJ Notification System)
Chapter 6 (Monetary & Non-monetary benefits)
Chapter 7 (Monitoring & Transparency)
Chapter 8 (TK)
Chapter 14 (Scientists & Commercial End Users)
Chapter 15 (Equity)
BBNJ Agreement & Official Website
Funded by the European Union under the Horizon Europe Programme, Grant Agreement No. 101082304 (BlueRemediomics). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the granting authority, the Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.
By ANCORSEpisode 2 goes from the negotiation room into the text of the treaty – to unpick what access and benefit sharing of Marine Genetic Resources really means. We explore what the treaty means in practice for scientists and commercial end users, what the provisions hold for Indigenous Peoples and local communities, and the relevance for future generations.
Guests
Co-Producers
Editing
Communications
Further readingHumphries, F. (ed.) (2025). Decoding Marine Genetic Resource Governance under the BBNJ Agreement (Springer) Chapter 5 (BBNJ Notification System)
Chapter 6 (Monetary & Non-monetary benefits)
Chapter 7 (Monitoring & Transparency)
Chapter 8 (TK)
Chapter 14 (Scientists & Commercial End Users)
Chapter 15 (Equity)
BBNJ Agreement & Official Website
Funded by the European Union under the Horizon Europe Programme, Grant Agreement No. 101082304 (BlueRemediomics). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the granting authority, the Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.